VINESSA MAXWELL: Open Payments
NPI 1881214377 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 22 payments from 8 companies in 2025. Trend: 2023 $565 · 2024 $267 · 2025 $723
Food & beverage: $502Education: $221
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $387 |
| Neurocrine BioSciences, Inc. | 3 | $89 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $22 |
Products named: INGREZZA, UZEDY, AUSTEDO XR, Auvelity, CAPLYTA, COBENFY, SPRAVATO, FANAPT.
Industry payments across NY — which companies pay providers there.
